Atrial FibrillationNCT04097132
Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals
An observational study of Atrial Fibrillation, run by Assiut University at 1 site in Egypt.
Trial summary
Pattern of non valvular Atrial fibrillation in acute ischemic stroke patients at Assiut University Hospitals. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Atrial Fibrillation
- What is being tested?
- echocardiography
- Type of treatment
- Medical device
- How many people
- 1 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2020to 1 Jan 2021
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study will include all cases of acute cerebrovascular stroke in Assiut university hospital
Who may be able to join
- Patients presented with acute cerebrovascular stroke aged more than 18 years old.
Who cannot join
- Patients below 18 years old.
- Patient admitted with cerebral hemohrrage.
- Patients with significant valvular heart disease.
Trial locations and contacts
1 site in 1 country.
Ayman khairy, assistatnt professor contact
Egypt1 site, 1 recruiting
- Recruiting
Shery Refaat Asaad
Asyut, 23123
Shery Asaad, resident, 01270992244, drshosho31'@yahoo.com
Ayman khairy, assistant professor, 01094438055
About this study
Pattern of non valvular Atrial fibrillation in acute ischemic stroke patients at Assiut University Hospitals.
Read the detailed description
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University and correlation between AF and severity of stroke at admission and discharge.
- Conditions
- Atrial Fibrillation
- Being tested
- echocardiography
- Medical subject headings
- Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
echocardiographyDevice
Also called holter
echocardiography for left atrial diameter, size ,Ejection Fraction Holter for detection of paroxusmal AF
| Study group | Role | What they receive |
|---|---|---|
| ischemic stroke patients | all patient admitted with acute ischemic stroke either their ECG was AF or sinus rythm Receives: Device: echocardiography |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University.
study the Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University whatever those patients have manifest atrial fibrillation or go into attacks of paroxysmal atrial fibrillation by the use of echocardiography for measurement of left atrial diameter and size and also by the use of Holter to identify any any attacks of paroxysmal atrial fibrillation
Measured: 1 year
Secondary outcomes (2)
correlation between AF and severity of stroke at admission and discharge.
relation between presence of AF and severity of stroke by the use of NIH Stroke Score and MRS score at time of admission and discharge.
Measured: 1 year
The role of anti coagulants in decreasing risk of ischemic cerebrovascular stroke in patients who are known to have Atrial Fibrillation and have been already anticoagulated
if the anticoagulant intake decrease stroke severity in patients who are already taking anticoagulants by the use of NIH Stroke Score and MRS score at time of admission and discharge
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Sep 2019
- Study start1 Jan 2020 (estimated)
- Primary completion1 Jan 2021 (estimated)
- Study completion1 Jan 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atrial FibrillationStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1 participants (estimated)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shery Refaat Asaad, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04097132
- Sponsor's protocol ID
- Pattern of non valvular AF
- Status last verified
- Sep 2019
- First submitted
- 18 Sep 2019
- Last updated
- 25 Sep 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals
- ClinicalTrials.gov ID
- NCT04097132
- Acronym / sponsor ID
- Pattern of non valvular AF
- Conditions
- Atrial Fibrillation
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Jan 2020 (estimated)
- Primary completion
- 1 Jan 2021 (estimated)
- Study completion
- 1 Jan 2021 (estimated)
- First posted
- 20 Sep 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pattern of non valvular Atrial fibrillation in acute ischemic stroke patients at Assiut University Hospitals.
Detailed description
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University and correlation between AF and severity of stroke at admission and discharge.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ischemic stroke patients | – | Device: echocardiographyall patient admitted with acute ischemic stroke either their ECG was AF or sinus rythm |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study will include all cases of acute cerebrovascular stroke in Assiut university hospital
Key inclusion criteria (1 listed)
- Patients presented with acute cerebrovascular stroke aged more than 18 years old.
Key exclusion criteria (3 listed)
- Patients below 18 years old.
- Patient admitted with cerebral hemohrrage.
- Patients with significant valvular heart disease.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| echocardiographyAlso: holterechocardiography for left atrial diameter, size ,Ejection Fraction Holter for detection of paroxusmal AF | Device | ischemic stroke patients |
Primary outcome
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University.
Time frame: 1 year
study the Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University whatever those patients have manifest atrial fibrillation or go into attacks of paroxysmal atrial fibrillation by the use of echocardiography for measurement of left atrial diameter and size and also by the use of Holter to identify any any attacks of paroxysmal atrial fibrillation
2 secondary outcomes
correlation between AF and severity of stroke at admission and discharge.
Time frame: 1 year
The role of anti coagulants in decreasing risk of ischemic cerebrovascular stroke in patients who are known to have Atrial Fibrillation and have been already anticoagulated
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2019.
Related trials for Atrial Fibrillation
Active, not recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
Paroxysmal AF
Active, not recruitingObservational study
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
Concomitant Procedures, Atrial Fibrillation
Active, not recruiting
CONVERGE Post-Approval Study (PAS)
Chronic Atrial Fibrillation
Recruiting
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Ischemic Stroke, Atrial Fibrillation
RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ayman khairy, assistatnt professor contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Atrial Fibrillation, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Shery Asaad, Resident (01270992244, drshosho31@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University. (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2019.